IL10 and Alzheimer disease: We found that the concentration of the anti‐inflammatory factor interleukin‐10 (IL‐10) was significantly higher in the US group compared to the AD group (1874.68 ± 131.14 pg/mL vs. 1335.83 ± 185.61 pg/mL, p < 0.05; Figure 2F).